Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDR®

Advances in implantable cardioverter defibrillator (ICD) technology have resulted in more effective defibrillation, and the need for defibrillation threshold (DFT) testing has been questioned.

[1]  I. Piña,et al.  Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. , 2010, Heart rhythm.

[2]  K. Schulman,et al.  Patient and Implanting Physician Factors Associated With Mortality and Complications After Implantable Cardioverter-Defibrillator Implantation, 2002–2005 , 2008, Circulation. Arrhythmia and electrophysiology.

[3]  D. Mark,et al.  No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). , 2008, Journal of the American College of Cardiology.

[4]  S. Rosenheck,et al.  Long-Term Follow-Up of Patients with Relatively High Effective Defibrillation Threshold during Cardioverter Defibrillator Implantation with Endocardial Leads , 2008, Cardiology.

[5]  K. Stolen,et al.  High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  J. Healey,et al.  Complications associated with defibrillation threshold testing: the Canadian experience. , 2008, Heart rhythm.

[7]  M. Brignole,et al.  Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  A. Russo,et al.  The Dilemma of ICD Implant Testing , 2007, Pacing and clinical electrophysiology : PACE.

[9]  A. Russo,et al.  Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors. , 2006, Heart rhythm.

[10]  D. Cohen,et al.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. , 2006, Journal of the American College of Cardiology.

[11]  L. Pires,et al.  Intraoperative Testing of the Implantable Cardioverter‐Defibrillator: How Much Is Enough? , 2006, Journal of cardiovascular electrophysiology.

[12]  A. Russo,et al.  Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? , 2005, Heart rhythm.

[13]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[14]  Michael O. Sweeney,et al.  Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.

[15]  G. Klein,et al.  Is defibrillation testing required for defibrillator implantation? , 2004, Journal of the American College of Cardiology.

[16]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[17]  V. Jayam,et al.  High Defibrillation Thresholds in Transvenous Biphasic Implantable Defibrillators: , 2003, Pacing and clinical electrophysiology : PACE.

[18]  M. Gold,et al.  Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation: Primary Results From the Low Energy Safety Study (LESS) , 2002, Circulation.

[19]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[20]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[21]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[22]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[23]  M. Gold,et al.  Effect of biphasic waveforms on transvenous defibrillation thresholds in patients with coronary artery disease. , 1997, The American journal of cardiology.

[24]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.

[25]  M. Gold,et al.  Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. , 1996, The American journal of cardiology.

[26]  R. Yee,et al.  Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. , 1996, Journal of the American College of Cardiology.

[27]  A. Natale,et al.  Comparison of Biphasic and Monophasic Pulses: Does the Advantage of Biphasic Shocks Depend on the Waveshape? , 1995, Pacing and clinical electrophysiology : PACE.

[28]  M. Schlepper,et al.  Effect of Biphasic Waveform Pulse on Endocardial Defibrillation Efficacy in Humans , 1994, Pacing and clinical electrophysiology : PACE.

[29]  George A. Johnson,et al.  A Simplified, Single‐Lead Unipolar Transvenous Cardioversion‐Defibrillation System , 1993, Circulation.

[30]  D. Wyse,et al.  Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. , 1993, The American journal of cardiology.

[31]  J. Fisher,et al.  Initial Experience with Transvenous Implantable Cardioverter Defibrillator Lead Systems: Operative Morbidity and Mortality , 1993, Pacing and clinical electrophysiology : PACE.